1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Germany >
  5. Repligen Acquires Atoll GmBH

M&A Deal Summary

Repligen Acquires Atoll GmBH

On April 4, 2016, Repligen acquired medical products company Atoll GmBH

Acquisition Highlights
  • This is Repligen’s 1st transaction in the Medical Products sector.
  • This is Repligen’s 1st transaction in Germany.

M&A Deal Summary
Date 2016-04-04
Target Atoll GmBH
Sector Medical Products
Buyer(s) Repligen
Deal Type Add-on Acquisition

Target

Atoll GmBH

Weingarten, Germany
Atoll GmBH is a manufacturer of MediaScout® pre-packed chromatography columns used in process development and clinical manufacturing of biologic drugs.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Repligen

Waltham, Massachusetts, United States
Category Company
Founded 1981
Sector Life Science
Employees1,778
Revenue 634M USD (2024)
DESCRIPTION

Repligen is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Repligen was founded in 1981 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 2 of 11
Sector: Medical Products M&A 1 of 4
Type: Add-on Acquisition M&A Deals 2 of 11
Country: Germany M&A 1 of 1
Year: 2016 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-27 Novozymes Biopharma Sweden AB

Lund, Sweden

Novozymes Biopharma Sweden AB is a manufactures biological products.

Buy €17M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-15 TangenX Technology

Shrewsbury, Massachusetts, United States

TangenX Technology Corp. is primarily engaged in the development, production and commercialization of innovative tangential flow filtration (TFF) membrane products for the biopharmaceutical industry.

Buy €37M
Mergr

Solution for

Product

Company

Legal